Evidence map›Paper›PMID 37173619›Full record

ArticleBMC cancer2023

Serum fatty acid profiles in breast cancer patients following treatment.

Alicja Pakiet, Agata Jędrzejewska, Katarzyna Duzowska, Alina Wacławska, Patrycja Jabłońska, Jacek Zieliński, Adriana Mika, Tomasz Śledziński, Ewa Słomińska

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Branched-Long-Chain Monomethyl Fatty Acids: Are They Hidden Gems?Journal of agricultural and food chemistry · 2023
    Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alicja PakietDepartment of Environmental Analysis, Faculty of Chemistry, University of Gdańsk, Wita Stwosza 63, 80-308, Gdańsk, Poland.
Agata JędrzejewskaDepartment of Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdańsk, Poland.
Katarzyna DuzowskaDepartment of Pharmaceutical Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdansk, Poland.
Alina WacławskaDepartment of Pharmaceutical Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdansk, Poland.
Patrycja JabłońskaDepartment of Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdańsk, Poland.
Jacek ZielińskiDepartment of Surgical Oncology, Medical University of Gdansk, Mariana Smoluchowskiego 17, 80-214, Gdańsk, Poland.
Adriana MikaDepartment of Pharmaceutical Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdansk, Poland. adriana.mika@gumed.edu.pl.
Tomasz ŚledzińskiDepartment of Pharmaceutical Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdansk, Poland.
Ewa SłomińskaDepartment of Biochemistry, Medical University of Gdańsk, Dębinki 1, 80-211, Gdańsk, Poland.
Gdańsk Medical University · PLUniversity of Gdańsk · PL

Funding

Narodowe Centrum Badań i Rozwoju STRATEGMED1/233226/11/NCBR/2015Narodowe Centrum Nauki 2020/37/N/NZ5/00726
6 · The paper itself

Abstract

backgroundBreast cancer is associated with alterations in lipid metabolism. The treatment of breast cancer can also affect serum lipid composition. The purpose of this study was the examination of serum fatty acids (FAs) profiles in breast cancer survivors to assess if the FA levels normalize.

methodsSerum levels of FAs were determined by gas chromatography-mass spectrometry in a group of breast cancer patients at baseline (before treatment, n = 28), at two follow-up visits at 12 months (n = 27) and 24 months (n = 19) after the breast cancer resection, and in the group of healthy controls (n = 25). Multivariate analysis was performed to assess how FA serum profile changes following treatment.

resultsBreast cancer patients' serum FA profiles at follow-ups did not normalize to the levels of control group. The greatest differences were found for levels of branched-chain (BCFA), odd-chain (OCFA) and polyunsaturated (PUFAs) FAs, all of which were significantly increased 12 months after the surgery.

conclusionsAfter treatment for breast cancer, the patients' serum FA profile differs from the profile before treatment and from controls, especially 12 months after treatment. Some changes may be beneficial - increased BCFA and OCFA levels, and improved n-6/n-3 PUFA ratio. This may reflect lifestyle changes in breast cancer survivors and have an impact on the risk of recurrence.

Indexed as

Breast NeoplasmsFatty AcidsFemaleHumansFatty AcidsBreast cancerFatty acidsGas chromatography-mass spectrometryLipidsSerum

Identifiers

PMID37173619
PMCPMC10176817
OpenAlexW4376631122

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.